Royalcare Super Speciality Hospitals
₹155▼3.13%(5.00)
About the company
Royal Care Super Specialty Hospital is one of Coimbatore's leading healthcare institutions, known for delivering high-quality, patient-focused medical care. Established on May 1, 2015, the hospital began its journey as a 50-bed multi-specialty hospital with a vision to provide advanced healthcare services supported by modern technology, experienced medical professionals, and compassionate patient care.
Within a short period, Royal Care earned the trust of patients and referring doctors across western Tamil Nadu through its commitment to clinical excellence, accurate diagnosis, and personalized treatment. The growing demand for its services led to a significant expansion, transforming the hospital into a comprehensive tertiary care center capable of handling complex medical and surgical cases across multiple specialties.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹160 |
| 52 week low | ₹125 |
| P/B ratio | 9.21 |
| Debt to equity | 1.34 |
| ROE (%) | 4.72% |
| Book value | ₹17.37 |
| Face value | ₹10 |
52 week high
52 week low
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| 52 week high | ₹160 |
| 52 week low | ₹125 |
| P/B ratio | 9.21 |
| Debt | 57.3% of capital |
| Equity | 42.7% of capital |
| ROE (%) | 4.72% |
Registry
| Metric | Value |
|---|---|
| PAN number | AAGCR1968R |
| ISIN number | INE02C801010 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 352 | 333 | 305 | 301 | 221 |
| EBITDA | 52 | 67 | 61 | 68 | 55 |
| OPM | 14.77 | 20.12 | 20 | 22.59 | 24.89 |
| PBT | 16 | 24 | 16 | 21 | 4 |
| PAT | 15 | 24 | 16 | 21 | 4 |
| EPS | 0.8 | 1.4 | 0.97 | 1.28 | 0.24 |
Shareholding Pattern
Promoters
Others
| Holder | Percentage |
|---|---|
| Promoters | 15.39% |
| Others | 84.61% |
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| Dr. K. Madeswaran | Chairman & MD | 25+ yrs experience | — |
| Dr. K. Chockalingam | Director | 25+ yrs experience | — |
| Sri. T.Balachander | Director & CFO | 25+ yrs experience | — |
Frequently asked questions
Common questions on Royalcare Super Speciality Hospitals—tap a row to read the answer.
Q.1What is Royal Care Super Specialty Hospital?
Royal Care Super Specialty Hospital is a healthcare provider based in Coimbatore, Tamil Nadu, offering multi-specialty and tertiary care medical services. Since its establishment in 2015, the hospital has expanded its infrastructure and healthcare capabilities to serve patients across western Tamil Nadu with advanced diagnostics, specialized treatments, and comprehensive medical care.
Q.2Is Royal Care Super Specialty Hospital a listed or an unlisted company?
Royal Care Super Specialty Hospital is an unlisted company, meaning its shares are not traded on the National Stock Exchange (NSE) or Bombay Stock Exchange (BSE). Investors interested in owning its shares must purchase them through the unlisted share market, subject to availability.
Q.3How can I buy Royal Care Super Specialty Hospital unlisted shares?
You can purchase Royal Care Super Specialty Hospital unlisted shares through the private unlisted market. The process generally includes completing KYC verification, confirming the latest share price and availability, making the payment, and receiving the shares directly into your Demat account through an off-market transfer. It's advisable to review the company's financial performance and valuation before investing.
Q.4. How can I sell Royal Care Super Specialty Hospital shares?
If you own Royal Care Super Specialty Hospital shares, you can sell them through the unlisted market by finding an interested buyer. Once both parties agree on the price, the shares are transferred from the seller's Demat account to the buyer's account, and the payment is settled as per the agreed terms.
Q.5What is the minimum investment required for Royal Care Super Specialty Hospital shares?
There is no fixed minimum investment amount. The investment depends on the prevailing unlisted share price, the number of shares available, and the minimum quantity offered by the seller. Since prices in the unlisted market can fluctuate, investors should verify the latest details before making a purchase.
Q.6Is it legal to buy Royal Care Super Specialty Hospital unlisted shares in India?
Yes. Investing in Royal Care Super Specialty Hospital unlisted shares is legal in India when the transaction complies with applicable regulations. Shares should be transferred through a registered Demat account, and investors should ensure all documentation and payment procedures are completed properly.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
